Rho-kinase inhibition by Fasudil promotes tumor maturation and apoptosis in small-cell lung cancer.
In conclusion, these results indicated a potential and novel application of Fasudil for SCLC treatment.
PMID: 32913511 [PubMed]
Source: American Journal of Translational Research - Category: Research Tags: Am J Transl Res Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Cardiology | Genetics | Heart | Lung Cancer | Neurology | Research | Small Cell Lung Cancer | Stem Cell Therapy | Stem Cells | Study